Hepatocellular carcinoma classification: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "__NOTOC__ {{Xyz}} {{CMG}}; {{AE}} ==Overview== There is no established system for the classification of [disease name]. OR [Disease name] may be classified according to [c...")
 
m (Bot: Removing from Primary care)
 
(53 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Xyz}}
{{Hepatocellular carcinoma}}


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{SH}}
==Overview==
==Overview==
There is no established system for the classification of [disease name].


OR
Hepatocellular carcinoma (HCC) may be classified into different [[histological]] subtypes based on the [[microscopic]] features. The [[TNM Staging System|TNM]] staging system is widely used for the staging of hepatocellular carcinoma, the Cancer of the Liver Italian Program (CLIP) system is used widely because it is adapted from the original Okuda classification system that takes [[cirrhosis]] into account.


[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
==Classification ==


OR
=== Classification based on histological features ===
*Hepatocellular carcinoma may be classified into different [[histological]] subtypes based on the [[microscopic]] features:<ref name="pmid268389792">{{cite journal |vauthors=Shafizadeh N, Kakar S |title=Hepatocellular Carcinoma: Histologic Subtypes |journal=Surg Pathol Clin |volume=6 |issue=2 |pages=367–84 |year=2013 |pmid=26838979 |doi=10.1016/j.path.2013.03.007 |url=}}</ref><ref name="pmid16178893">{{cite journal |vauthors=Matsuura S, Aishima S, Taguchi K, Asayama Y, Terashi T, Honda H, Tsuneyoshi M |title='Scirrhous' type hepatocellular carcinomas: a special reference to expression of cytokeratin 7 and hepatocyte paraffin 1 |journal=Histopathology |volume=47 |issue=4 |pages=382–90 |year=2005 |pmid=16178893 |doi=10.1111/j.1365-2559.2005.02230.x |url=}}</ref><ref name="DrebberDienes2006">{{cite journal|last1=Drebber|first1=U.|last2=Dienes|first2=H. P.|title=Diagnose und Differenzialdiagnose des hepatozellulären Karzinoms|journal=Der Pathologe|volume=27|issue=4|year=2006|pages=294–299|issn=0172-8113|doi=10.1007/s00292-006-0842-1}}</ref>
**[[Fibrolamellar hepatocellular carcinoma|Fibrolamellar carcinoma]] 
**Sarcomatoid HCC
**[[Undifferentiated]] carcinoma
**Combined HCC-[[cholangiocarcinoma]] (HCC-CC)
**[[Lymphoepithelioma]]
**Scirrhous hepatocellular carcinoma (scirrhous HCC)
**[[Trabecula|Trabecular]] hepatocellular carcinoma
**Pseudoglandular hepatocellular carcinoma
**[[Acinar]] hepatocellular carcinoma
**Compact hepatocellular carcinoma
{{familytree/start}}
{{familytree | | | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | | | | |A01= Hepatocellular carcinoma}}
{{familytree | | | | |,|-|-|-|v|-|-|-|-|v|-|^|-|v|-|-|-|-|v|-|-|-|.| }}
{{familytree | | | | |!| | | |!| | | | |!| | | |!| | | | |!| | | |!| | | | | | }}
{{familytree | | | | C01 | | C02 | | | C03 | | C04 | | | C05 | | C06 | | | |C01 = [[Fibrolamellar hepatocellular carcinoma|Fibrolamellar carcinoma]]  | C02 = [[Undifferentiated]] carcinoma  | C03 = Sarcomatoid HCC  | C04 = Combined HCC-CC* | C05 = [[Lymphoepithelioma]]|C06=Scirrhous HCC}}
{{familytree/end}}


[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].
<small>
[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
'''Abbreviations:'''
Combined HCC-[[cholangiocarcinoma]] (HCC-CC)*
</small>


OR
===Classification based on TNM staging===
According to the [[TNM staging system]], there are four stages of hepatocellular carcinoma based on the [[tumor]] size, [[lymph node]] involvement, and distant [[metastasis]]. Although the [[TNM staging system]] is widely used for the staging of hepatocellular carcinoma, the Cancer of the Liver Italian Program (CLIP) system is preferable because it is adopted from the original Okuda classification system that takes [[cirrhosis]] into account.
====TNM staging system====


Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
According to the [[TNM staging system]], there are four stages of hepatocellular carcinoma based on the [[tumor]] size, [[lymph node]] involvement, and distant [[metastasis]].<ref name="cancerca">Canadian Cancer Society.http://www.cancer.ca/en/cancer-information/cancer-type/liver/staging/?region=ab</ref>


OR
===Primary tumor===
{| {{table}} cellpadding="4" cellspacing="0" style="border:#c9c9c9 1px solid; margin: 1em 1em 1em 0; border-collapse: collapse;"
|'''Primary tumor'''
|'''Interpretation'''
|-
||TX
||Primary [[tumor]] cannot be assessed
|-
| T0||No evidence of [[primary tumor]]
|-
| T1||A single [[tumor]] with no invasion into the [[blood vessels]] of the [[liver]]
|-
| T2||A single [[tumor]] with invasion into the [[blood vessels]] or multiple [[tumors]], none more than 5 cm in size
|-
| T3a||Multiple [[tumors]], with any tumor larger than 5 cm
|-
| T3b||The [[tumor]] has grown into either the [[Portal vein|portal]] or [[hepatic vein]]
|-
| T4||The [[tumor]] has grown into nearby organs (other than the [[gallbladder]]) or the [[tumor]] has grown into the layer of [[Tissue (biology)|tissue]] that covers the [[Organ (anatomy)|organs]] in the [[abdomen]] ([[visceral peritoneum]])
|}


If the staging system involves specific and characteristic findings and features:
===Regional lymph node===
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].


OR
{| {{table}} cellpadding="4" cellspacing="0" style="border:#c9c9c9 1px solid; margin: 1em 1em 1em 0; border-collapse: collapse;"
|'''Lymph node involvement'''
|'''Interpretation'''
|-
| NX||Regional [[lymph nodes]] cannot be assessed
|-
| N0||No regional [[lymph node]] [[metastasis]]
|-
| N1||Regional [[lymph node]] [[metastasis]]
|}


The staging of [malignancy name] is based on the [staging system].
===Distant metastasis===


OR
{| {{table}} cellpadding="4" cellspacing="0" style="border:#c9c9c9 1px solid; margin: 1em 1em 1em 0; border-collapse: collapse;"
| M0
|No distant [[metastasis]]
|-
| M1||Distant [[metastasis]]
|}


There is no established system for the staging of [malignancy name].
===Clip and Okuda staging systems for hepatocellular carcinoma===
Cancer of the Liver Italian Program (CLIP) system is used widely because it is adopted from the original Okuda classification system that takes [[cirrhosis]] into account.


==Classification==
'''CLIP Classification'''
{| class="wikitable"
! style="background:#4479BA; color: #FFFFFF;" align="center" |Variable
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Points
|-
|
|0
|1
|2
|-
|'''i.'''Tumor number (%)
|Single
|Multiple
|–
|-
|[[Hepatic]] replacement by [[tumor]]
|<50
|<50
|>50
|-
|'''ii.''' [[Child-Pugh score]]
|A
|B
|C
|-
|'''iii.''' [[Alpha-fetoprotein|α fetoprotein level]] (ng/mL)
|<400
|≥400
|–
|-
|'''iv'''.[[Portal vein thrombosis]] (CT) 
|No
|Yes
|–
|-
| colspan="4" |CLIP stages (score = sum of points): CLIP 0, 0 points; CLIP 1, 1 point; CLIP 2, 2 points; CLIP 3, more than 3
points.
|}
'''OKUDA'''  '''Classification'''
{| class="wikitable"
| colspan="8" style="background:#4479BA; color: #FFFFFF;" align="center" |'''OKUDA Classification'''
|-
| colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Tumor extent<sup>a</sup>''' 
| colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Bilirubin (mg/dL)'''
| colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Albumin (g/L)'''
| colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Ascites'''
|-
|≥50%
|<50
|≥ 3
|<3
|≤3
|>3
| +
|–
|-
|(+)
|(−)
|(+)
|(−)
|(+)
|(−)
|(+)
|(−)
|-
| colspan="8" |Okuda stages: stage 1, all (−); stage 2, 1 or 2 (+); stage 3, 3 or 4 (+)
|}
a. Liver span occupied by the [[tumor]].


*There is no established system for the classification of [disease name].
<small>
OR
'''Adopted from Harrison's Textbook of Medicine*'''
*[Disease name] may be classified according to [classification method] into [number] subtypes/groups:
</small>
**[Group1]
**[Group2]
**[Group3]
**[Group4]
OR
*[Disease name] may be classified into [large number > 6] subtypes based on:
**[Classification method 1]
**[Classification method 2]
**[Classification method 3]
*[Disease name] may be classified into several subtypes based on:
**[Classification method 1]
**[Classification method 2]
**[Classification method 3]
OR
*Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
*If the staging system involves specific and characteristic findings and features:
*According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
*The staging of [malignancy name] is based on the [staging system].
OR
*There is no established system for the staging of [malignancy name].


==References==
==References==
Line 64: Line 162:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category: (name of the system)]]
 
[[Category:Disease]]
[[Category:Medicine]]
[[Category:Gastroenterology]]
[[Category:Types of cancer]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Hepatology]]
[[Category:Surgery]]
[[Category:Emergency medicine]]

Latest revision as of 22:07, 29 July 2020

Hepatocellular carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes of Hepatocellular carcinoma

Differentiating Hepatocellular carcinoma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

Diagnostic study of choice

History and symptoms

Physical Examination

Lab Tests

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatocellular carcinoma classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatocellular carcinoma classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatocellular carcinoma classification

CDC on Hepatocellular carcinoma classification

Hepatocellular carcinoma classification in the news

Blogs on Hepatocellular carcinoma classification

Directions to Hospitals Treating Hepatocellular carcinoma

Risk calculators and risk factors for Hepatocellular carcinoma classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2]

Overview

Hepatocellular carcinoma (HCC) may be classified into different histological subtypes based on the microscopic features. The TNM staging system is widely used for the staging of hepatocellular carcinoma, the Cancer of the Liver Italian Program (CLIP) system is used widely because it is adapted from the original Okuda classification system that takes cirrhosis into account.

Classification

Classification based on histological features

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hepatocellular carcinoma
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fibrolamellar carcinoma
 
Undifferentiated carcinoma
 
 
Sarcomatoid HCC
 
Combined HCC-CC*
 
 
Lymphoepithelioma
 
Scirrhous HCC
 
 
 

Abbreviations: Combined HCC-cholangiocarcinoma (HCC-CC)*

Classification based on TNM staging

According to the TNM staging system, there are four stages of hepatocellular carcinoma based on the tumor size, lymph node involvement, and distant metastasis. Although the TNM staging system is widely used for the staging of hepatocellular carcinoma, the Cancer of the Liver Italian Program (CLIP) system is preferable because it is adopted from the original Okuda classification system that takes cirrhosis into account.

TNM staging system

According to the TNM staging system, there are four stages of hepatocellular carcinoma based on the tumor size, lymph node involvement, and distant metastasis.[4]

Primary tumor

Primary tumor Interpretation
TX Primary tumor cannot be assessed
T0 No evidence of primary tumor
T1 A single tumor with no invasion into the blood vessels of the liver
T2 A single tumor with invasion into the blood vessels or multiple tumors, none more than 5 cm in size
T3a Multiple tumors, with any tumor larger than 5 cm
T3b The tumor has grown into either the portal or hepatic vein
T4 The tumor has grown into nearby organs (other than the gallbladder) or the tumor has grown into the layer of tissue that covers the organs in the abdomen (visceral peritoneum)

Regional lymph node

Lymph node involvement Interpretation
NX Regional lymph nodes cannot be assessed
N0 No regional lymph node metastasis
N1 Regional lymph node metastasis

Distant metastasis

M0 No distant metastasis
M1 Distant metastasis

Clip and Okuda staging systems for hepatocellular carcinoma

Cancer of the Liver Italian Program (CLIP) system is used widely because it is adopted from the original Okuda classification system that takes cirrhosis into account.

CLIP Classification

Variable Points
0 1 2
i.Tumor number (%) Single Multiple –
Hepatic replacement by tumor <50 <50 >50
ii. Child-Pugh score A B C
iii. α fetoprotein level (ng/mL) <400 ≥400 –
iv.Portal vein thrombosis (CT) No Yes –
CLIP stages (score = sum of points): CLIP 0, 0 points; CLIP 1, 1 point; CLIP 2, 2 points; CLIP 3, more than 3

points.

OKUDA Classification

OKUDA Classification
Tumor extenta Bilirubin (mg/dL) Albumin (g/L) Ascites
≥50% <50 ≥ 3 <3 ≤3 >3 + –
(+) (−) (+) (−) (+) (−) (+) (−)
Okuda stages: stage 1, all (−); stage 2, 1 or 2 (+); stage 3, 3 or 4 (+)

a. Liver span occupied by the tumor.

Adopted from Harrison's Textbook of Medicine*

References

  1. ↑ Shafizadeh N, Kakar S (2013). "Hepatocellular Carcinoma: Histologic Subtypes". Surg Pathol Clin. 6 (2): 367–84. doi:10.1016/j.path.2013.03.007. PMID 26838979.
  2. ↑ Matsuura S, Aishima S, Taguchi K, Asayama Y, Terashi T, Honda H, Tsuneyoshi M (2005). "'Scirrhous' type hepatocellular carcinomas: a special reference to expression of cytokeratin 7 and hepatocyte paraffin 1". Histopathology. 47 (4): 382–90. doi:10.1111/j.1365-2559.2005.02230.x. PMID 16178893.
  3. ↑ Drebber, U.; Dienes, H. P. (2006). "Diagnose und Differenzialdiagnose des hepatozellulären Karzinoms". Der Pathologe. 27 (4): 294–299. doi:10.1007/s00292-006-0842-1. ISSN 0172-8113.
  4. ↑ Canadian Cancer Society.http://www.cancer.ca/en/cancer-information/cancer-type/liver/staging/?region=ab

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Hepatocellular_carcinoma_classification&oldid=1639247"